Thousands of men with advanced prostate cancer will be denied a life-extending drug after officials deemed it was not cost-effective. The drug abiraterone cuts the risk of men dying within three years by a third. But the tablets are only offered on the NHS after patients have had gruelling chemotherapy …...Read More